Portfolio Analysis
Explore the global R&D pipeline for each global health area, disease or product type through two lenses. Use the Explore visual insights view to analyze portfolio trends through interactive charts and maps, or switch to the Extract custom details tab to build a filtered data table tailored to your needs and export your findings as a .csv file for further analysis.
Global pipeline overview
A global overview of the R&D pipeline by product type and development stage. Each horizontal bar represents a product type, with colour‑coded segments showing how many candidates and approved products sit at each stage of the R&D lifecycle, from discovery and pre‑clinical through clinical phases to approval. Use the filters above to narrow the view by global health area, disease, or product type, and click items in the legend to toggle individual stages on or off and compare where activity is concentrated across the pipeline.
Product types
A snapshot of how the R&D pipeline is distributed across product types. Click on the drop-down to toggle between candidates, approved products or both.
Aggregated portfolio
The aggregated portfolio lets you deepdive into four key views of the pipeline: active candidates, approved products, clinical trials and technology types. They can be accessed via the tabs below. All views reflect the pagelevel filters.
Selected candidates
0 candidatesThis matrix grid shows candidates in development on your current page filter, with a text search option to quickly find specific records. It provides candidate level details such as name, R&D stage, developer, indication and additional attributes to support deeper portfolio analysis.
| Name | GHA | Disease | Secondary disease | Product | R&D stage | Developers | Indication | Indication type | Health care facility level | Target | Mechanism of action | Technology type | Test format | Preclinical results status | Type of preclinical results | Preclinical results source | Key features and challenges | Recent updates |
|---|